{
    "nctId": "NCT00290654",
    "briefTitle": "Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ",
    "officialTitle": "Twin Cities Brachytherapy Study for Ductal Carcinoma in Situ A Phase II Trial",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Number of Patients With Ipsilateral Breast Tumor Recurrence",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Ductal carcinoma in situ (DCIS) confirmed by excisional or needle biopsy\n* Size: \\< 3 cm on mammogram\n* Unicentric disease\n* Ability to place MammoSite device at time of lumpectomy or within 4 weeks of lumpectomy\n* Patient Age: \u2265 18 years, no upper limit\n* Life expectancy \\> 5 years\n\nExclusion Criteria:\n\n* Prior history of cancer other than basal or squamous cell skin cancer or in situ cancer of the cervix\n* Pregnant or breast feeding\n* Multicentric disease\n* Diagnosis of collagen vascular diseases, such as systemic lupus erythematosis, scleroderma, or dermatomyositis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}